0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query hjresearch global alzheimers disease treatments industry market research 2019.Your search for "" gave back 1533063 results.
The Nuclear Imaging industry plays a crucial role in diagnostic medicine, offering innovative imaging techniques that utilize radioactive tracers to...
Catalog:
HJResearch
June 2023
Price: USD 3,200.00
Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2) Drugs in Development by Therapy Areas and...
Catalog:
Global Markets Direct
April 2022
Price: USD 3,500.00
The global Alzheimer Disease Genetic Testing market size is projected to grow from US$ 109.6 million in 2022 to US$ 372.2 million in 2029; it is...
Catalog:
LPI
May 2023
Price: USD 3,660.00
Muscarinic Acetylcholine Receptor M2 - Pipeline Review, H2 2020 Summary Muscarinic Acetylcholine Receptor M2 (CHRM2) - Muscarinic cholinergic...
Catalog:
Global Markets Direct
October 2020
Price: USD 3,500.00
There is no cure for Alzheimer's disease, but promising drugs have emerged in recent years that can help stop the disease's progression...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The global Alzheimer Disease Genetic Testing market size is expected to reach $ 358.7 million by 2029, rising at a market growth of 17.6% CAGR during...
Catalog:
GIR
May 2023
Price: USD 4,480.00
Alzheimer's disease is a neurodegenerative disorder that affects memory, cognitive functions, and behavior. While there is no cure for Alzheimer...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Mild Cognitive Impairment - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
September 2018
Price: USD 2,000.00
Muscarinic Acetylcholine Receptor M4 (CHRM4) - Pipeline Review, H1 2018 Summary Muscarinic Acetylcholine Receptor M4 (CHRM4) - Muscarinic...
Catalog:
Global Markets Direct
June 2018
Price: USD 3,500.00
Progressive Supranuclear Palsy - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
Catalog:
Global Markets Direct
June 2018
Price: USD 2,000.00
Alzheimer’s is a neurodegenerative progressive disease. Alzheimer's disease is a type of dementia whichludes a broad group of brain diseasessuch...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Alzheimer Disease Genetic Testing market size was valued at USD 115.2 million in 2022 and is forecast to a readjusted size of USD 358.7...
Catalog:
GIR
May 2023
Price: USD 3,480.00
Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) - Pipeline Review, H1 2018 Summary...
Catalog:
Global Markets Direct
January 2018
Price: USD 3,500.00
C5a Anaphylatoxin Chemotactic Receptor 1 - Pipeline Review, H2 2019 Summary C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Complement...
Catalog:
Global Markets Direct
November 2019
Price: USD 3,500.00
Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H2 2018 Summary Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7)...
Catalog:
Global Markets Direct
July 2018
Price: USD 3,500.00
